NOI - Olink Explore HT Proteomic Analysis for Sickle Cell Disease Study

The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive, firm-fixed-price purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform to support a longitudinal study on transthyretin variants in sickle cell disease severity. The contract requires quantification of over 5,400 proteins per sample through standardized sample processing, assay execution using Olink Proximity Extension Assay technology, rigorous quality control, and delivery of normalized, analysis-ready datasets fully compatible with existing longitudinal data. The award is being made under FAR 6.302-3(a)(2)(ii) because PSOmagen, Inc. is identified as the only responsible source capable of meeting the technical and programmatic requirements, ensuring continuity with previously generated datasets. The solicitation, identified as 75N98026Q00281, is issued as a Notice of Intent with responses due by May 13, 2026, and must be submitted electronically to the designated point of contact. Offerors are required to hold active SAM registration with a valid UEI and TIN, and must complete FAR 52.212-3 representations and certifications. The acquisition is classified under NAICS code 541380 with no set-aside restrictions, allowing both small and other-than-small businesses to respond, although only one offeror has been deemed capable. The place of performance is Rockville, Maryland, while deliverables are to be accepted at the NHLBI facility in Bethesda, Maryland. Evaluation will follow FAR 52.212-2, considering factors such as past performance, special features, and warranty, but no formal weights, ratings, or trade-off analysis will be applied. The contract complies with FAR Part 12 commercial item procedures, incorporating clauses 52.212-1 through 52.212-5, and requires submission of detailed pricing, delivery terms, F.O.B. point, and product documentation. No physical packaging, marking, or shipping standards apply as no tangible goods are involved. Invoicing methods, payment offices, accounting codes, and COR/COTR designations are not specified in the notice, and no contract options, security clearances, or organizational conflict of interest provisions are included.